Unmethylated CpG-oligodeoxynucleotides (CpG-ODNs) are recognized as a 'danger signal' and are potent immunostimulators. To test whether tumors might be prevented by maintaining the innate immune system on continuous alert, proto-neu transgenic female mice, which develop spontaneous mammary tumors, were systemically treated with CpG-ODNs at 10-day intervals. Tumor incidence and number of tumors/mouse were significantly lower in treated mice compared with the control group. Moreover, CpG-ODN systemic treatment significantly reduced lung metastases induced by intravenous inoculation of N202.1A cells derived from a spontaneous mammary carcinoma. Growth of established tumors was modestly inhibited after CpG-ODN systemic treatment but strongly on peritumoral application. Our data indicate that systemic repeated injection of CpG-ODN to maintain the innate immune system on continuous alert prevents the onset of genetically determined tumors and confers tumor protection when the tumor load is low.

Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA / L. Sfondrini, D. Besusso, C. Rumio, M. Rodolfo, S. Menard, A. Balsari. - In: THE FASEB JOURNAL. - ISSN 0892-6638. - 16:13(2002 Nov), pp. 1749-1754.

Prevention of spontaneous mammary adenocarcinoma in HER-2/neu transgenic mice by foreign DNA

L. Sfondrini
Primo
;
D. Besusso;C. Rumio;A. Balsari
Ultimo
2002

Abstract

Unmethylated CpG-oligodeoxynucleotides (CpG-ODNs) are recognized as a 'danger signal' and are potent immunostimulators. To test whether tumors might be prevented by maintaining the innate immune system on continuous alert, proto-neu transgenic female mice, which develop spontaneous mammary tumors, were systemically treated with CpG-ODNs at 10-day intervals. Tumor incidence and number of tumors/mouse were significantly lower in treated mice compared with the control group. Moreover, CpG-ODN systemic treatment significantly reduced lung metastases induced by intravenous inoculation of N202.1A cells derived from a spontaneous mammary carcinoma. Growth of established tumors was modestly inhibited after CpG-ODN systemic treatment but strongly on peritumoral application. Our data indicate that systemic repeated injection of CpG-ODN to maintain the innate immune system on continuous alert prevents the onset of genetically determined tumors and confers tumor protection when the tumor load is low.
CpG-oligodeoxynucleotides; Danger signal; Innate immunity; Murine tumors
Settore MED/04 - Patologia Generale
Settore BIO/16 - Anatomia Umana
nov-2002
http://www.fasebj.org/cgi/content/full/16/13/1749
Article (author)
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/26335
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 29
social impact